Bendic Health Care Private Limited

Benvastin-ASP Capsules combine Rosuvastatin, a potent statin for lipid control, with Aspirin, an antiplatelet agent, to provide comprehensive cardiovascular risk management. This dual-action formulation is widely prescribed for patients with dyslipidemia and increased risk of heart attack or stroke, helping manage cholesterol levels while reducing platelet aggregation.

Key Benefits & Uses:

• Lowers LDL cholesterol and triglycerides

• Helps prevent blood clot formation with antiplatelet action

• Reduces risk of heart attack, stroke, and atherosclerotic events

• Suitable for patients with high cardiovascular risk

• Supports long-term cardio-protective therapy

Why Choose Benvastin-ASP:

• Dual benefit of lipid lowering + antiplatelet protection

• Simplifies therapy with a single capsule

• Manufactured under stringent quality standards by Bendic Healthcare Pvt. Ltd.

Ideal For:
Cardiology clinics, hospitals, physicians, and retail pharmacies seeking a reliable Rosuvastatin + Aspirin capsule for secondary prevention and long-term cardiovascular care.

Cilnidic-5 Tablet contains Cilnidipine 5 mg, a newer generation calcium channel blocker used for effective management of hypertension (high blood pressure). Cilnidipine acts on both L-type and N-type calcium channels, helping relax blood vessels, reduce peripheral resistance, and maintain stable blood pressure with better tolerability.

Key Benefits & Uses:

• Effective control of high blood pressure

• Provides smooth and sustained BP reduction

• Helps reduce stress-related sympathetic activity

• Lower risk of reflex tachycardia and pedal edema compared to conventional CCBs

• Suitable for long-term hypertension management

Why Choose Cilnidic-5:

• Advanced dual calcium channel blocking action

• Supports cardiovascular protection with good patient compliance

• Manufactured under strict quality standards by Bendic Healthcare Pvt. Ltd.

Ideal For:
Cardiology clinics, general physicians, hospitals, and retail pharmacies looking for a reliable Cilnidipine 5 mg tablet for routine and long-term hypertension therapy.

Daploben-V Tablet is a dual-mechanism oral anti-diabetic medicine formulated for effective management of Type 2 Diabetes Mellitus. It combines Dapagliflozin, an SGLT2 inhibitor that promotes urinary glucose excretion, with Vildagliptin SR, a DPP-4 inhibitor that enhances incretin activity and supports insulin secretion. The sustained-release profile of Vildagliptin ensures prolonged glycemic control with improved patient adherence.

Key Benefits & Uses:

• Improves fasting and post-prandial blood glucose control

• Helps reduce HbA1c through complementary mechanisms

• Low risk of hypoglycemia when used appropriately

• Supports weight neutrality or modest weight reduction

• Once-daily dosing with sustained glycemic coverage

Why Choose Daploben-V:

• Synergistic SGLT2 inhibitor + DPP-4 inhibitor combination

• Sustained-release Vildagliptin for consistent control

• Manufactured under stringent quality standards by Bendic Healthcare Pvt. Ltd.

Ideal For:
Diabetologists, physicians, hospitals, and retail pharmacies seeking a reliable Dapagliflozin + Vildagliptin SR tablet for comprehensive Type 2 diabetes management.